These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2509116

  • 1. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
    Hellstrand K, Hermodsson S.
    Clin Exp Immunol; 1989 Sep; 77(3):410-6. PubMed ID: 2509116
    [Abstract] [Full Text] [Related]

  • 2. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR, Kamber M, Peck R.
    Lymphokine Res; 1987 Sep; 6(3):215-27. PubMed ID: 3114569
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM, Zhu HG, Anderer FA.
    Anticancer Res; 1993 Sep; 13(4):923-30. PubMed ID: 8352560
    [Abstract] [Full Text] [Related]

  • 5. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B, Rees RC.
    Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
    [Abstract] [Full Text] [Related]

  • 6. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 7. Role of serotonin in the regulation of human natural killer cell cytotoxicity.
    Hellstrand K, Hermodsson S.
    J Immunol; 1987 Aug 01; 139(3):869-75. PubMed ID: 2439597
    [Abstract] [Full Text] [Related]

  • 8. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET, Babbitt JT, Kawakami K.
    J Immunol; 1986 Jul 01; 137(1):172-8. PubMed ID: 3711665
    [Abstract] [Full Text] [Related]

  • 9. rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.
    Ben Aribia MH, Leroy E, Lantz O, Métivier D, Autran B, Charpentier B, Hercend T, Senik A.
    J Immunol; 1987 Jul 15; 139(2):443-51. PubMed ID: 3110271
    [Abstract] [Full Text] [Related]

  • 10. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G, Masera RG, Pallavicini L, Sartori ML, Staurenghi A, Orlandi F, Angeli A.
    Brain Behav Immun; 1993 Mar 15; 7(1):16-28. PubMed ID: 8386029
    [Abstract] [Full Text] [Related]

  • 11. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL, Benike CJ, Phillips JH, Engleman EG.
    J Immunol; 1985 Feb 15; 134(2):794-801. PubMed ID: 3871216
    [Abstract] [Full Text] [Related]

  • 12. Role of monocytes in the augmentation of human natural killer cell activity by interleukin-2.
    Suzuki H, Yamashita N, Sugiyama E, Sato M, Ito M, Yano S.
    Anticancer Res; 1984 Feb 15; 4(1-2):63-7. PubMed ID: 6608916
    [Abstract] [Full Text] [Related]

  • 13. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA, Brahmi Z.
    J Immunol; 1988 Nov 01; 141(9):3164-9. PubMed ID: 3262683
    [Abstract] [Full Text] [Related]

  • 16. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity.
    Cordero OJ, Sarandeses CS, López JL, Nogueira M.
    Lymphokine Cytokine Res; 1992 Oct 01; 11(5):277-85. PubMed ID: 1467368
    [Abstract] [Full Text] [Related]

  • 17. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
    Hogan PG, Hapel AJ, Doe WF.
    J Immunol; 1985 Sep 01; 135(3):1731-8. PubMed ID: 3926882
    [Abstract] [Full Text] [Related]

  • 18. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G.
    Cell Immunol; 1994 Jul 01; 156(2):480-92. PubMed ID: 7912999
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
    Kaasinen ES, Harju LM, Timonen TT.
    J Urol; 2002 May 01; 167(5):2209-14. PubMed ID: 11956480
    [Abstract] [Full Text] [Related]

  • 20. Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.
    Cutts JL, Bankhurst AD.
    J Cell Physiol; 1990 Nov 01; 145(2):244-52. PubMed ID: 2246324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.